In this short video clip, Dr. Stephen T. Colbert, D.F.A., discusses how manufacturing problems at Genzyme (NASDAQ:GENZ) will aid the upcoming launch of Prescott Pharmaceuticals' new Vaxafilth product. Isn't it time that filth wallowed in you?
Full disclosure: Prescott is one of my consulting clients. I advised them on the trade strategy for Vaxadrin.
Click here to catch up on all of Dr. Colbert's Cheating Death news segments.
"Prescott Pharmaceuticals: guaranteed to change your life, and possibly your genetic code."